Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Event-Driven Study to Investigate the Effect of Retatrutide on the Incidence of Major Adverse Cardiovascular Events and the Decline in Kidney F
Sponsored by Eli Lilly and Company
Active
$704.8K Funding
4 People
External
Related Topics
cardiovascular health,
kidney function,
drug efficacy,
clinical trials,
diabetes management
People
Elena Young
(CD)
College of Medicine - Phoenix
﹒Research Compliance Manager II
Mason Burchfield
(CD)
College of Medicine - Phoenix
﹒Research Compliance Administrator III
Roderick Tung
Principal Investigator (PI)
College of Medicine - Phoenix
﹒Chief
Arianna Bedoya
(CD)
College of Medicine - Phoenix
﹒Clinical Research Coordinator III
